Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

265 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Health Care In The Year Of The Ox: Navigating China's Dynamic M&A Market

    Despite the challenges presented by the pandemic, the Chinese health care sector continues to be fertile ground for both inbound and outbound M&A activity.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Winston Taylor
    Winston Taylor
  • Article

    New Regime For Cosmetic Products Registration

    Following a governmental bodies’ reorganization, the State Food and Drug Administration ("SFDA") has officially taken over the authority from the Ministry of Health ("MOH") to examine and approve all application for cosmetic products registration in China since September 2008.
    ChinaFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
Article

China Expands Pilot Program For Foreign Investment In The Healthcare Sector

On September 7, China's Ministry of Commerce, the National Health Commission, and the National Medical Products Administration issued a notice announcing the expansion of pilot programs for foreign investment...
ChinaGovernment, Public Sector
Sheppard
Sheppard
  • Article

    중국 제약산업협회, 2019년 제약산업의 지식재산권 발전현황 보고서 발표

    2020년 6월 28일, 중국 제약산업협회(医药物资协会)는 ‘2019년 중국 제약 지식재산권 산업 발전 현황 보고(2019年度中国医药知识产权行业发展状况报告)'를 발표함
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    Distressed Business Opportunities Amidst The COVID-19 Outbreak - Learning To Dance In The Rain

    The unravelling COVID-19 coronavirus situation has caused significant financial distress in East Asia, and is now making its presence felt in the European and American markets.
    GlobalFood, Drugs, Healthcare, Life Sciences
    Withers LLP
    Withers LLP
  • Article

    China Compliance Update – Summer 2025

    Anti-corruption has remained an area of focus area for Chinese authorities in the first half of 2025, with major legislative updates and enforcement cases.
    ChinaCriminal Law
    Arnold & Porter
    Arnold & Porter
  • Article

    Chinese FDA Released Guidelines For Rx-OTC Switch

    The State Food and Drug Administration recently announced a set of technical guidelines for switching prescription drugs to over-the-counter drugs.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    观点 | 《医疗器械管理法(草案)》十大亮点快评

    2024年8月28日,国家药监局发布了《医疗器械管理法(草案征求意见稿)》(以下简称"《征求意见稿》")并向社会公开征求意见。这距离2023年9月7日ʌ
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    China takes steps to enforce food safety standards

    Looks at new food safety laws being enforced in China.
    ChinaConsumer Protection
    Norton Rose Fulbright Australia
    Norton Rose Fulbright Australia
  • Article

    China Tightens The Reins: Anti-Corruption Compliance Expectations For Companies In The Healthcare Sector

    This month, as part of China's ongoing anti-corruption campaign in the healthcare sector, the State Administration for Market Regulation (SAMR) issued the Compliance Guidelines...
    ChinaCriminal Law
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China's Central Government Introduces Major Policy Incentives And Restraints To The MedTech Industry

    After continuously reshaping the competitive landscape in the pharmaceutical industry for several years, the Chinese government finally shifted its attention to the medtech industry.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China's Health Authorities Issue New Rules on Telemedicine

    The Measures clarify longstanding ambiguities regarding the scope of permitted telemedicine.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Life Sciences Compliance Update: Kickback And Third-Party Case Study

    A recent criminal judgment published by the Gao'an People's Court in Jiangxi province (江西省高安市人民法院) in June 2025 has drawn public attention to Jiangxi Baishen Pharmaceutical Co.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    HHS Launches Operation TrialBlazer To Advance US Clinical Research Leadership

    The US Department of Health and Human Services has launched Operation TrialBlazer to address China's growing dominance in clinical research and restore American leadership in biomedical innovation. As Chinese clinical trials now surpass US trials in both speed and volume, this comprehensive initiative aims to modernize regulatory processes, reduce administrative burdens, and reverse the trend of research investment flowing overseas.
    ChinaFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Schulte
    McDermott Will & Schulte
  • Article

    Discussion On The Patent Eligibility Of Smart Healthcare

    The rapid advancement of artificial intelligence technology is reshaping the technical boundaries within the medical and healthcare techniques.
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    Mornington 2000 LLP (T/a Sterilab Services) & Anor V The Secretary Of State For Health And Social Care

    The dispute here arose out of a contract for the supply of COVID-19 lateral flow test kits. In order to perform the contract, the second claimant ("Santé") had a subcontract with a German supplier ("Bio").
    ChinaFood, Drugs, Healthcare, Life Sciences
    Fenwick Elliott LLP
    Fenwick Elliott LLP
  • Article

    China Life Sciences Compliance Update: Insurance Fraud Enforcement Campaign And New Ethical Code For HCPs

    Chinese authorities have launched a special "Hundred-Day Campaign" to target misconduct relating to China's state-run medical insurance program and issued a new Ethical Code for Healthcare Professionals...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Regulation Of Medical Advertisements

    With over 1.35 billion people, healthcare in China is already a huge, and growing, market..
    ChinaFood, Drugs, Healthcare, Life Sciences
    Clyde & Co
    Clyde & Co
  • Article

    Survival Of The Fittest Or Cheapest?

    T he past year is set to be a milestone year for China's pharmaceutical regulatory reform as the newly formed National Medical Products Administration (NMPA) continues to aggressively cut back on red
    ChinaFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    The promotion of private healthcare services- A challenge or an opportunity?

    To address China's aging population issue and to improve access in rural areas, healthcare reform has become a priority.
    ChinaFood, Drugs, Healthcare, Life Sciences
    King & Wood Mallesons
    King & Wood Mallesons
  • Showing 41–60 of 265 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics